LON:INDV - Indivior Share Price, Forecast & News

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

4 brokerages have issued 1-year price targets for Indivior's stock. Their forecasts range from GBX 39 to GBX 150. On average, they expect Indivior's share price to reach GBX 106.33 in the next year. This suggests a possible upside of 191.0% from the stock's current price. View Analyst Price Targets for Indivior.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Indivior.

Press coverage about INDV stock has been trending neutral on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Indivior earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave headlines about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Indivior.

Some companies that are related to Indivior include Endonovo Therapeutics (ENDV), Phibro Animal Health (PAHC), Tivity Health (TVTY), Twist Bioscience (TWST), Luminex (LMNX), NextCure (NXTC), Natus Medical (NTUS), Portola Pharmaceuticals (PTLA), Myovant Sciences (MYOV), Opko Health (OPK), Knight Therapeutics (GUD), Akebia Therapeutics (AKBA), Enanta Pharmaceuticals (ENTA), Cryolife (CRY) and Dermira (DERM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Futura Medical (FUM), Bigblu Broadband (BBB), Directa Plus (DCTA), Lakehouse (LAKE), Umicore (UMI), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY) and Deltex Medical Group (DEMG).

Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of INDV stock can currently be purchased for approximately GBX 36.54.

Indivior has a market capitalization of £267.37 million and generates £889 million in revenue each year. Indivior employs 915 workers across the globe.View Additional Information About Indivior.

The official website for Indivior is http://indivior.com/.

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.